Entero Therapeutics Files 8-K on Shareholder Vote Matters
Ticker: GRDX · Form: 8-K · Filed: Jul 2, 2025 · CIK: 1604191
| Field | Detail |
|---|---|
| Company | Entero Therapeutics, Inc. (GRDX) |
| Form Type | 8-K |
| Filed Date | Jul 2, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote, company-name-change
TL;DR
Entero Therapeutics (formerly First Wave BioPharma) filed an 8-K on June 30th regarding shareholder vote matters.
AI Summary
Entero Therapeutics, Inc. (formerly First Wave BioPharma, Inc.) filed an 8-K on July 2, 2025, reporting on a submission of matters to a vote of security holders as of June 30, 2025. The company, incorporated in Delaware with its principal office in Boca Raton, Florida, is in the pharmaceutical preparations industry.
Why It Matters
This filing indicates a formal process of seeking shareholder approval for certain corporate actions, which could impact the company's strategic direction and governance.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of a shareholder vote matter and does not inherently present new financial or operational risks.
Key Players & Entities
- Entero Therapeutics, Inc. (company) — Registrant
- First Wave BioPharma, Inc. (company) — Former company name
- AzurRx BioPharma, Inc. (company) — Former company name
- BioPharma d'Azur, Inc. (company) — Former company name
- June 30, 2025 (date) — Date of earliest event reported
- July 2, 2025 (date) — Filing date
FAQ
What specific matters were submitted to a vote of Entero Therapeutics' security holders?
The filing states that it is a 'Submission of Matters to a Vote of Security Holders' but does not detail the specific matters within the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on June 30, 2025.
What is the current name of the company that was formerly known as First Wave BioPharma, Inc.?
The company formerly known as First Wave BioPharma, Inc. is now Entero Therapeutics, Inc.
In which state is Entero Therapeutics, Inc. incorporated?
Entero Therapeutics, Inc. is incorporated in Delaware.
What is the business address of Entero Therapeutics, Inc.?
The business address is 777 Yamato Road, Suite 502, Boca Raton, Florida 33431.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 2, 2025 regarding Entero Therapeutics, Inc. (GRDX).